tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Paul Massoud, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst Paul Massoud, carries an average stock price target met ratio of 83.33% that have a potential upside of 53% achieved within 1308 days. Previously, Paul Massoud worked at STIFEL.
Paul Massoud’s has documented 18 price targets and ratings displayed on 3 stocks. The coverage was on the Basic Materials sector.
Most recent stock forecast was given on AA, Alcoa Corp at 12-Apr-2016.
Analyst best performing recommendations are on MBII (MARRONE BIO INNOVATIONS).
The best stock recommendation documented was for MBII (MARRONE BIO INNOVATIONS) at 8/27/2013. The price target of $17 was fulfilled within 30 days with a profit of $3.74 (28.21%) receiving and performance score of 9.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jan-2026
$64
$7.19 (12.66%)
$71
13 days ago
(23-Jan-2026)
23/26 (88.46%)
$1.79 (2.88%)
505
Hold Since 14-Jul-2023
$50
$-6.81 (-11.99%)
$45
28 days ago
(08-Jan-2026)
13/17 (76.47%)
$-12.74 (-20.31%)
133
Buy Since 21-Feb-2023
$54
$-2.81 (-4.95%)
$42
1 months 17 days ago
(19-Dec-2025)
21/22 (95.45%)
$5.82 (12.08%)
335
Hold Since 15-May-2025
$34
$-22.81 (-40.15%)
$31
4 months 17 days ago
(19-Sep-2025)
2/2 (100%)
$1.54 (4.74%)
31
Sell Since 17-Jul-2025
$27
$-29.81 (-52.47%)
$43
6 months 19 days ago
(17-Jul-2025)
6/7 (85.71%)
$-2.29 (-7.82%)
362
What Year was the first public recommendation made by Paul Massoud?
